XBiotech Inc. (XBIT)

XBiotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	201.04	200.02	217.48	236.98	237.37	714.59
Cash & Cash Equivalents	201.04	200.02	217.48	236.98	237.37	714.59
Cash Growth	-5.47%	-8.03%	-8.23%	-0.16%	-66.78%	4416.17%
Receivables	0	0	0	0	79.18	75
Other Current Assets	2.02	1.7	2.37	9.89	9.33	-73.33
Total Current Assets	203.06	201.72	219.84	246.87	325.88	716.26
Property, Plant & Equipment	24.8	24.9	26.26	28.31	27.34	25.17
Other Long-Term Assets	0	0	0	0	0.53	75.44
Total Long-Term Assets	24.8	24.9	26.26	28.31	27.87	100.61
Total Assets	227.86	226.62	246.1	275.18	353.74	816.88
Accounts Payable	2.61	2.52	2.41	2.07	2.49	2.15
Deferred Revenue	0	0	0	0	0	4.5
Current Debt	10	0	0	0	0	0
Other Current Liabilities	4.28	3.58	1.66	1.38	1.49	53.54
Total Current Liabilities	16.88	6.1	4.07	3.45	3.98	60.19
Other Long-Term Liabilities	1.69	1.67	1.64	2.34	1.12	1.06
Total Long-Term Liabilities	1.69	1.67	1.64	2.34	1.12	1.06
Total Liabilities	18.58	7.77	5.7	5.79	5.11	61.25
Total Debt	10	0	0	0	0	0
Retained Earnings	-62.31	-52.31	-27.75	5.15	97.57	430.93
Comprehensive Income	0	0	0.83	1.97	1.27	-0.11
Shareholders' Equity	209.28	218.85	240.4	269.39	348.64	755.63
Net Cash / Debt	191.04	200.02	217.48	236.98	237.37	714.59
Net Cash / Debt Growth	-10.17%	-8.03%	-8.23%	-0.16%	-66.78%	4416.17%
Net Cash Per Share	6.28	6.57	7.14	7.89	7.70	15.43
Working Capital	186.17	195.62	215.78	243.42	321.89	656.07
Book Value Per Share	6.87	7.19	7.90	8.97	11.31	19.40

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).